SARS-CoV-2 shedding, infectivity, and evolution in an immunocompromised adult patient. uri icon

Overview

abstract

  • This study aimed to provide further insight into the evolutionary dynamics of SARS-CoV-2 by analyzing the case of a 40-year-old man who had previously undergone autologous hematopoietic stem cell transplantation due to a diffuse large B-cell lymphoma. He developed a persistent SARS-CoV-2 infection lasting at least 218 days and did not manifest a humoral immune response to the virus during this follow-up period. Whole-genome sequencing and viral cultures confirmed a persistent infection with a replication-positive virus that had undergone genetic variation for at least 196 days after symptom onset.

publication date

  • May 13, 2024

Research

keywords

  • COVID-19
  • Immunocompromised Host
  • SARS-CoV-2
  • Virus Shedding

Identity

PubMed Central ID

  • PMC11095242

Scopus Document Identifier

  • 85193206605

Digital Object Identifier (DOI)

  • 10.1590/S1678-9946202466028

PubMed ID

  • 38747849

Additional Document Info

volume

  • 66